Clinical trial
Impact of a Sequential Isokinetic Fatigue Protocol Followed by Ankle Strengthening After Botulinum Toxin Injection Into Spastic Plantar Flexors on Foot Lift Strength and Walking
NCT07260565 is registered in ClinicalTrials.gov with Clinique Victor Pauchet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of a Sequential Isokinetic Fatigue Protocol Followed by Ankle Strengthening After Botulinum Toxin Injection Into Spastic Plantar Flexors on Foot Lift Strength and Walking
- Lead sponsor
- Clinique Victor Pauchet
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 1, 2026
- Completion date
- November 1, 2028
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
spasticity of the plantar flexors